SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-072467
Filing Date
2024-06-12
Accepted
2024-06-12 16:17:22
Documents
11
Period of Report
2024-06-11
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K pyxs-20240611.htm   iXBRL 8-K 59916
  Complete submission text file 0000950170-24-072467.txt   177867

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT pyxs-20240611.xsd EX-101.SCH 25998
14 EXTRACTED XBRL INSTANCE DOCUMENT pyxs-20240611_htm.xml XML 4911
Mailing Address 321 HARRISON AVENUE BOSTON MA 02118
Business Address 321 HARRISON AVENUE BOSTON MA 02118 (617) 221-9059
Pyxis Oncology, Inc. (Filer) CIK: 0001782223 (see all company filings)

IRS No.: 831160910 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40881 | Film No.: 241038620
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)